Table 4.
miRNAs | Source | Model | miRNA levels | Putative targets | Pathogenic role | Reference |
---|---|---|---|---|---|---|
21 | Glomeruli Kidney |
DM2 patients with albuminuria, STZ-DM mice | ↑ |
SMAD7, TGF-βR2 PDCD4, Col4a1, TIMP3 |
↓ fibrosis, ↓ podocyte damage | [42] |
Kidney | db/db mice KK/Ay mice |
↑ | SMAD7 | ↑ fibrosis, ↑ inflammation | [44, 45] | |
Kidney | OVE26 mice | ↑ | PTEN | ↑ fibrosis | [43] | |
Glomeruli | db/db mice | ↓ | PTEN | ↑ fibrosis | [72] | |
25 | Kidney | DM2 patients with DN STZ-DM rats STZ-DM mice and db/db mice |
↓ |
PTEN
NOX4 CDC42 |
↑ oxidative stress, ↑ apoptosis, ↑ fibrosis, ↑ podocyte injury | [66–68] |
26a | Glomeruli | DM2 patients with DN STZ-DM mice |
↓ | CTGF | ↑ fibrosis | [102] |
27a | Glomeruli Kidney |
DM2 patients with DN STZ-DM rats |
↑ | PPAR-γ | ↑ podocyte damage, ↑ fibrosis | [58, 101] |
29a | Glomeruli | STZ-DM mice | ↓ | HDAC4 | ↑ podocyte injury, ↑ fibrosis | [54] |
29b | Kidney | db/db mice | ↓ | SP1 | ↑ fibrosis, ↑ inflammation | [38] |
29c | Glomeruli | db/db mice | ↑ | SPRY1 | ↑ fibrosis, ↑ podocyte injury | [59] |
34a | Glomeruli | db/db mice | ↑ | GAS1 | Glomerular hypertrophy | [69] |
93 | Glomeruli Kidney |
db/db mice DM patients with DN |
↓ | MSK2/VEGF | ↑ VEGF, podocyte damage | [55, 56] |
130b | Glomeruli | STZ-DM mice | ↓ | TGF-βR1 | ↑ fibrosis | [89] |
Kidney | DM2 patients and STZ-DM rats | ↓ | SNAIL | ↑ EMT | [105] | |
135a | Kidney | DM patients with DN and db/db mice |
↑ | TRPC1 | ↑ fibrosis | [103] |
146a | Kidney | DM2 patients with DN, STZ-DM rats and DM2 rats STZ-DM mice and db/db mice |
↑ | IRAK1, TRAF6 | ↓ inflammation, ↓ fibrosis | [28] |
DM2 patients and ob/ob mice | ↓ | ERB-B4, NOTCH-1 | ↑ podocyte injury | [33] | ||
155 | Kidney | DM2 patients with DN, STZ-DM rats and DM2 rats STZ-DM mice |
↑ | SOCS1 | ↓ inflammation, ↑ podocyte damage | [28, 57] |
192 | Kidney | Patients with advanced DN ApoE-KO DM mice |
↓ | ZEB1/2 | ↑ EMT, ↑ fibrosis (tubule-interstitial) | [91, 92] |
Glomeruli Kidney |
STZ-DM mice and db/db mice DM2 patients with early DN |
↑ | ZEB1/2 | ↑ fibrosis (glomeruli) | [77, 78, 80] | |
195 | Glomeruli Kidney |
STZ-DM mice (proteinuric) | ↑ | BCL2 | ↑ podocyte damage/apoptosis | [63] |
Kidney | Early DN mice | ↓ | BCL2 | ↑ mesangial cell proliferation | [64] | |
215 | Glomeruli Kidney |
db/db mice | ↑ | CTNNBIP1 | ↑ EMT | [104] |
Kidney | ApoE-KO STZ mice | ↓ | ZEB2 | ↑ EMT, ↑ fibrosis | [87] | |
216a | Glomeruli | STZ-DM mice and db/db mice | ↑ | YBX1 | ↑ fibrosis | [81] |
200b | Kidney | ApoE KO STZ mice | ↓ | ZEB1/2, FN | ↑ EMT | [93–95] |
200b/c | Glomeruli | STZ-DM mice and db/db mice | ↑ | FOG2, ZEB1 | Glomerular hypertrophy | [73, 79] |
377 | Kidney | STZ-DM mice and NOD mice | ↑ | PAK1, SOD2 | ↑ fibrosis | [90] |
let-7a | Kidney | DM2 patients with early DN STZ-DM rats |
↓ |
UHRF1
TGF-βR1 |
↑ fibrosis | [88, 96] |
let-7/7b | Glomeruli Kidney |
ApoE-KO STZ mice | ↓ |
Col1a2, Col4a1 TGF-βR1 |
↑ fibrosis | [85, 86] |
STZ: streptozotocin; DM: diabetes; DN: diabetic nephropathy; KO: knockout; EMT: epithelial mesenchymal transition.